Cover Image

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

Treatment options for extended-spectrum β-lactamase-producing Enterobacteriaceae are limited. Piperacillin-tazobactam and cefepime represent potential alternative treatment options; however, large prospective studies are lacking. This review evaluates the current literature regarding use of piperaci...

Full description

Saved in:

Bibliographic Details
Main Authors:	Allison M. Gibble (Author), Alan E. Gross (Author), Angela M. Huang (Author)
Format:	Book
Published:	MDPI AG, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates
by: Gopal Nandlal Agrawal, et al.
Published: (2017)

Analyses of Extended-Spectrum-β-Lactamase, Metallo-β-Lactamase, and AmpC-β-Lactamase Producing Enterobacteriaceae from the Dairy Value Chain in India
by: Tushar Kumar Dey, et al.
Published: (2023)

Multimodal Interventions to Prevent and Control Carbapenem-Resistant Enterobacteriaceae and Extended-Spectrum β-Lactamase Producer-Associated Infections at a Tertiary Care Hospital in Egypt
by: Noha A. Kamel, et al.
Published: (2021)

Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?
by: Ji Young Park
Published: (2021)

Detection of Extended-Spectrum β-lactamase-producing Enterobacteriaceae in a Healthcare Center from Maracaibo city, Venezuela
by: Armindo Perozo Mena, et al.
Published: (2017)

Prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in wastewater: a systematic review and meta-analysis
by: Nawel Zaatout, et al.
Published: (2021)

Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing <i>Enterobacteriaceae</i>: A Cross-Sectional Study
by: Muhammad Muqaddas Mustafai, et al.
Published: (2023)

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain
by: Khalid Mubarak Bindayna, et al.
Published: (2009)

Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae</i> in Critically Ill Patients
by: Wen-Liang Yu, et al.
Published: (2020)

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals
by: Chien-Hao Tseng, et al.
Published: (2023)

Clinical Outcomes of Non-carbapenem Treatment for Urinary Tract Infections Caused by Extended-spectrum β-lactamase-producing
by: Eunae Kim, et al.
Published: (2021)

Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon
by: Karyom Djim-, et al.
Published: (2023)

Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae
by: Nadeem Sajjad Raja
Published: (2019)

The fly route of extended-spectrum-β-lactamase-producing Enterobacteriaceae dissemination in a cattle farm: from the ecosystem to the molecular scale
by: Alann Caderhoussin, et al.
Published: (2024)

Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales
by: Amy Y. Kang, et al.
Published: (2024)

Diagnosis and Management of Infections Caused by Enterobacteriaceae Producing Extended-Spectrum b-Lactamase
by: Audrey Amelia, et al.
Published: (2016)

Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors
by: Nakita Reddy, et al.
Published: (2023)

Bloodstream Infections by Extended-spectrum β-lactamase-producing Klebsiella Species in Children
by: Aysun Yahşi, et al.
Published: (2023)

Characterization of Extended-Spectrum β-Lactamase-Producing and AmpC β-Lactamase-Producing <i>Enterobacterales</i> Isolated from Companion Animals in Korea
by: Se Ra Shin, et al.
Published: (2021)

Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae
by: Hong Luo, et al.
Published: (2021)

Colonization of extended-spectrum β-lactamase-producing Enterobacteriaceae does not affect subsequent infection and liver transplant outcomes: a retrospective observational cohort study
by: Chen Shang, et al.
Published: (2023)

Prevalence and Risk Factors of β-Lactamase Genes of Extended-Spectrum β-Lactamases-Producing From Dairy Farm Environments of Haryana, India
by: Sarin Kamboj, et al.
Published: (2024)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021)

In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria
by: Patrik Mlynarcik, et al.
Published: (2021)

Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli
by: Ubaid Rasool, et al.
Published: (2018)

Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli
by: Kyo Jin Jo, et al.
Published: (2021)

High Carriage of Extended-Spectrum, Beta Lactamase-Producing, and Colistin-Resistant Enterobacteriaceae in Tibetan Outpatients with Diarrhea
by: Zhe Li, et al.
Published: (2022)

A Study of Extended Spectrum Β-Lactamase (ESBL) And AMPC Β-Lactamase Producing Klebsiella Pneumoniae in Neonatal Intensive Care Unit at Tertiary Care Hospital, Ahmedabad
by: Dhara J Modi, et al.
Published: (2012)

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants
by: Yun Hee Kim, et al.
Published: (2017)

Urinary tract infection caused by community‐acquired extended‐spectrum β‐lactamase‐producing bacteria in infants
by: Yun Hee Kim, et al.
Published: (2017)

Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by: Luiza Arcas Gonçalves, et al.
Published: (2024)

Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal
by: Raju Shrestha, et al.
Published: (2019)

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants
by: Yun Hee Kim, et al.

Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing <i>Klebsiella pneumoniae</i>
by: Lei Zha, et al.
Published: (2022)

Transmission Chains of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae at the Companion Animal Veterinary Clinic-Household Interface
by: Kira Schmitt, et al.
Published: (2021)

Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates
by: Rachel Burgoon, et al.
Published: (2023)

Predicting Extended-Spectrum Beta-Lactamase and Carbapenem Resistance in Enterobacteriaceae Bacteremia: A Diagnostic Model Systematic Review and Meta-Analysis
by: Tristan T. Timbrook, et al.
Published: (2023)

Reduced susceptibility to extended-spectrum β-lactams in V. cholerae isolated in Bangladesh
by: Daniela Ceccarelli, et al.
Published: (2016)

Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Isolated from Food-Producing Animals in Tamaulipas, Mexico
by: Antonio Mandujano, et al.
Published: (2023)

Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations
by: Darren J. Bentley
Published: (2024)